Data is not available at this time.
Oxford Instruments plc operates as a leading provider of high-technology tools and systems for research and industrial applications, serving sectors such as semiconductors, renewable energy, and healthcare. The company’s diversified portfolio includes atomic force microscopy, etch and deposition processing equipment, low-temperature systems, and nuclear magnetic resonance instruments, catering to specialized markets with high barriers to entry. Its solutions are critical for advanced research in quantum technology, materials science, and life sciences, positioning it as a key enabler of innovation. Oxford Instruments maintains a strong global presence, with operations spanning the UK, China, Japan, the US, and Europe. The company’s focus on niche, high-margin markets allows it to command premium pricing and foster long-term customer relationships. Its expertise in precision instrumentation and analytical systems differentiates it from broader industrial competitors, reinforcing its leadership in scientific and industrial research tools. By continuously investing in R&D and strategic acquisitions, Oxford Instruments strengthens its technological edge and expands its addressable market.
Oxford Instruments reported revenue of £470.4 million for FY 2024, with net income of £50.7 million, reflecting a disciplined approach to cost management and operational efficiency. The company generated £42.4 million in operating cash flow, though capital expenditures of £27.0 million indicate ongoing investments in growth initiatives. Its ability to maintain profitability in a capital-intensive industry underscores its competitive positioning.
The company’s diluted EPS of 87p demonstrates its earnings resilience, supported by a diversified revenue base and high-margin product lines. Oxford Instruments’ capital efficiency is evident in its ability to generate positive cash flow while funding R&D and strategic expansions, ensuring sustainable returns for shareholders.
Oxford Instruments maintains a robust balance sheet, with £97.8 million in cash and equivalents against £47.4 million in total debt, reflecting a conservative leverage profile. This financial stability provides flexibility for strategic investments and mitigates risks associated with cyclical demand in its end markets.
The company has demonstrated consistent growth, driven by demand for advanced research tools and industrial applications. Its dividend per share of 21p reflects a commitment to returning capital to shareholders while retaining sufficient funds for reinvestment. Oxford Instruments’ growth trajectory is supported by secular trends in semiconductor and renewable energy markets.
With a market capitalization of approximately £1.05 billion and a beta of 0.98, Oxford Instruments is valued as a stable, growth-oriented player in the technology sector. The market appears to price in its leadership in niche markets and its ability to sustain margins despite macroeconomic uncertainties.
Oxford Instruments’ strategic advantages lie in its technological expertise, global footprint, and focus on high-growth sectors like quantum technology and advanced materials. The outlook remains positive, supported by increasing R&D spending across industries and the company’s ability to innovate. Long-term growth will likely hinge on its capacity to expand into emerging markets and maintain its technological leadership.
Company filings, London Stock Exchange disclosures
show cash flow forecast
| Fiscal year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | 2050 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |